Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Non-interventional study

Non-interventional study design

Cross-sectional
Study drug and medical condition

Medical condition to be studied

Type 2 diabetes mellitus
Population studied

Age groups

Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

1500
Study design details

Main study objective

to assess the level of blood glucose, measured by the proportion of patients attaining the blood glucose control target defined as HbA1c<7%.

Outcomes

The primary outcome is the proportion of patients attaining blood glucose control target defined as HbA1c<7%, according to 2015 American Diabetes Association (ADA) and 2013 Chinese Diabetes Society (CDS) guidelines. Renal function level of patientsTreatment regimens for T2DM that patient are currently takingProportion of macro vascular and micro vascular diabetic complicationsProportion of Hypoglycaemic occurrenceProportion of Hypoglycaemia leading to therapy changeProportion of Anti-hypertension therapy usageProportion of Lipid Lowering therapy usageProportion of Anti-Platelet therapy usage

Data analysis plan

Descriptive statistics such as mean, standard deviation, median and range (minimum, maximum) will be used to summarize continuous variables. Counts and percentages will be used to summarize categorical variables. The chi-square test will be used to compare the categorical data between groups and the t-test will be used to compare the continuous variables that are normally distributed. For variables that are not normally distributed, non-parametric tests will be used.To identify the factors associated with overall blood glucose control, a stepwise logistic regression will be used.Missing data will not be imputed. Statistical significance will be assessed at a two-sided 0.05 level in an explorative way. All analysis will be conducted using SAS software.